NetworkNewsBreaks – Pressure BioSciences Inc. (P
Post# of 1354
(Total Views: 159)
Posted On: 08/30/2018 5:34:30 PM
NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Issued Key U.S. Patent for High-Pressure Flow-Through Microfluidic Sample Preparation Device
Pressure BioSciences (OTCQB: PBIO) this morning announced the award of a key new U.S. patent, entitled ”Flow-through High Hydrostatic Pressure Microfluidic Sample Preparation Device and Related Methods Therefor.” The company’s creation provides a path for integration of automated ”Hands-Free” sample prep workflows utilizing PBIO’s patented high-pressure platform technologies. The newly issued patent brings Pressure BioSciences’ Intellectual Property (”IP”) to a total of 21 issued patents. “This long-anticipated patent is a very important development for the Company on multiple fronts, and the timing of its issuance could not be better. This invention covers key elements of our plans for developing automated, ”hands-free” sample handling for the next generation of our high-pressure sample preparation platform technologies. This invention also enables a unique capability for maintaining high pressure in a flow-through format (rather than current batch processing), which we expect will facilitate the development of new, automated continuous process monitoring tools applicable to diverse segments of the life sciences industry. Finally, we believe this novel flow-through concept offers critical enablement for future system design strategies for epitope characterization, an emerging area in development and production of biotherapeutics that could revolutionize personalized therapy for numerous medical conditions, including autoimmune diseases and a variety of rare medical disorders,” Pressure BioSciences Vice President of Research and Development Dr. Alexander Lazarev stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO) this morning announced the award of a key new U.S. patent, entitled ”Flow-through High Hydrostatic Pressure Microfluidic Sample Preparation Device and Related Methods Therefor.” The company’s creation provides a path for integration of automated ”Hands-Free” sample prep workflows utilizing PBIO’s patented high-pressure platform technologies. The newly issued patent brings Pressure BioSciences’ Intellectual Property (”IP”) to a total of 21 issued patents. “This long-anticipated patent is a very important development for the Company on multiple fronts, and the timing of its issuance could not be better. This invention covers key elements of our plans for developing automated, ”hands-free” sample handling for the next generation of our high-pressure sample preparation platform technologies. This invention also enables a unique capability for maintaining high pressure in a flow-through format (rather than current batch processing), which we expect will facilitate the development of new, automated continuous process monitoring tools applicable to diverse segments of the life sciences industry. Finally, we believe this novel flow-through concept offers critical enablement for future system design strategies for epitope characterization, an emerging area in development and production of biotherapeutics that could revolutionize personalized therapy for numerous medical conditions, including autoimmune diseases and a variety of rare medical disorders,” Pressure BioSciences Vice President of Research and Development Dr. Alexander Lazarev stated in the news release.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Pressure Biosciences (PBIO) Stock Research Links
Scroll down for more posts ▼